- Home
- SGMT vs JELD Comparison
SGMT vs JELD Comparison
Compare SGMT & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGMT | JELD |
|---|---|---|
| Founded | 2006 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Forest Products |
| Sector | | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 138.7M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SGMT | JELD |
|---|---|---|
| Price | $6.76 | $1.86 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 6 |
| Target Price | ★ $26.13 | $3.43 |
| AVG Volume (30 Days) | 742.9K | ★ 1.5M |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,000,000.00 | ★ $3,211,181,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.50 | $0.93 |
| 52 Week High | $11.41 | $6.98 |
Technical Indicators
Market Signals| Indicator | SGMT | JELD |
|---|---|---|
| Relative Strength Index (RSI) | 46.60 | 56.08 |
| Support Level | $6.33 | $1.70 |
| Resistance Level | $7.39 | $2.15 |
| Average True Range (ATR) | 0.39 | 0.18 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 33.91 | 59.20 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.